232 related articles for article (PubMed ID: 27506746)
1. Validation of a metabolite panel for early diagnosis of type 2 diabetes.
Carter TC; Rein D; Padberg I; Peter E; Rennefahrt U; David DE; McManus V; Stefanski E; Martin S; Schatz P; Schrodi SJ
Metabolism; 2016 Sep; 65(9):1399-408. PubMed ID: 27506746
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes.
Al-Kafaji G; Al-Mahroos G; Alsayed NA; Hasan ZA; Nawaz S; Bakhiet M
Mol Med Rep; 2015 Nov; 12(5):7485-90. PubMed ID: 26460159
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?
Savolainen O; Fagerberg B; Vendelbo Lind M; Sandberg AS; Ross AB; Bergström G
PLoS One; 2017; 12(7):e0177738. PubMed ID: 28692646
[TBL] [Abstract][Full Text] [Related]
4. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study.
Wilkinson L; Yi N; Mehta T; Judd S; Garvey WT
PLoS Med; 2020 Aug; 17(8):e1003232. PubMed ID: 32764746
[TBL] [Abstract][Full Text] [Related]
6. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
[TBL] [Abstract][Full Text] [Related]
7. Early metabolic markers identify potential targets for the prevention of type 2 diabetes.
Peddinti G; Cobb J; Yengo L; Froguel P; Kravić J; Balkau B; Tuomi T; Aittokallio T; Groop L
Diabetologia; 2017 Sep; 60(9):1740-1750. PubMed ID: 28597074
[TBL] [Abstract][Full Text] [Related]
8. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort.
Shi L; Brunius C; Lehtonen M; Auriola S; Bergdahl IA; Rolandsson O; Hanhineva K; Landberg R
Diabetologia; 2018 Apr; 61(4):849-861. PubMed ID: 29349498
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
10. Potential role of liver enzyme levels as predictive markers of glucose metabolism disorders in a Tunisian population.
Bouhajja H; Abdelhedi R; Amouri A; Hadj Kacem F; Marrakchi R; Safi W; Mrabet H; Chtourou L; Charfi N; Fourati M; Bensassi S; Jamoussi K; Abid M; Ayadi H; Mnif-Feki M; Bougacha-Elleuch N
Can J Physiol Pharmacol; 2018 Nov; 96(11):1171-1180. PubMed ID: 29527933
[TBL] [Abstract][Full Text] [Related]
11. The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction.
Janghorbani M; Almasi SZ; Amini M
Acta Diabetol; 2015 Aug; 52(4):781-8. PubMed ID: 25572334
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach.
Menni C; Fauman E; Erte I; Perry JR; Kastenmüller G; Shin SY; Petersen AK; Hyde C; Psatha M; Ward KJ; Yuan W; Milburn M; Palmer CN; Frayling TM; Trimmer J; Bell JT; Gieger C; Mohney RP; Brosnan MJ; Suhre K; Soranzo N; Spector TD
Diabetes; 2013 Dec; 62(12):4270-6. PubMed ID: 23884885
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive 13C-glucose breath test using residual gas analyzer-mass spectrometry: a novel tool for screening individuals with pre-diabetes and type 2 diabetes.
Ghosh C; Maity A; Banik GD; Som S; Chakraborty A; Selvan C; Ghosh S; Ghosh B; Chowdhury S; Pradhan M
J Breath Res; 2014 Sep; 8(3):036001. PubMed ID: 24946152
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional study of the determinants and associations of sex hormone-binding globulin concentrations in first degree relatives (FDR) of patients with Type 2 Diabetes Mellitus.
Abdella NA; Mojiminiyi OA
Diabetes Res Clin Pract; 2017 Nov; 133():159-167. PubMed ID: 28950181
[TBL] [Abstract][Full Text] [Related]
15. Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes.
Gar C; Rottenkolber M; Prehn C; Adamski J; Seissler J; Lechner A
Crit Rev Clin Lab Sci; 2018 Jan; 55(1):21-32. PubMed ID: 29239245
[TBL] [Abstract][Full Text] [Related]
16. Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls.
Canivell S; Rebuffat S; Ruano EG; Kostov B; Sisó-Almirall A; Novials A; Ceriello A; Gomis R
Diabetes Metab Res Rev; 2015 Feb; 31(2):212-9. PubMed ID: 25139699
[TBL] [Abstract][Full Text] [Related]
17. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.
Guasch-Ferré M; Ruiz-Canela M; Li J; Zheng Y; Bulló M; Wang DD; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Serra-Majem L; Liang L; Papandreou C; Dennis C; Martínez-González MA; Hu FB; Salas-Salvadó J
J Clin Endocrinol Metab; 2019 May; 104(5):1508-1519. PubMed ID: 30423132
[TBL] [Abstract][Full Text] [Related]
18. Changes in Plasma Metabolome Profiles Following Oral Glucose Challenge among Adult Chinese.
Huo S; Sun L; Zong G; Shen X; Zheng H; Jin Q; Li H; Yin H; Lin X
Nutrients; 2021 Apr; 13(5):. PubMed ID: 33925473
[TBL] [Abstract][Full Text] [Related]
19. Area under the curve during OGTT in first-degree relatives of diabetic patients as an efficient indicator of future risk of type 2 diabetes and prediabetes.
Feizi A; Meamar R; Eslamian M; Amini M; Nasri M; Iraj B
Clin Endocrinol (Oxf); 2017 Dec; 87(6):696-705. PubMed ID: 28793372
[TBL] [Abstract][Full Text] [Related]
20. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans.
Lee JW; Lim NK; Park HY
BMC Endocr Disord; 2018 May; 18(1):33. PubMed ID: 29843706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
